Ani Pharmaceuticals Inc 8-K Filing
Ticker: ANIP · Form: 8-K · Filed: Dec 1, 2025 · CIK: 1023024
| Field | Detail |
|---|---|
| Company | Ani Pharmaceuticals Inc (ANIP) |
| Form Type | 8-K |
| Filed Date | Dec 1, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Ani Pharmaceuticals Inc (ticker: ANIP) to the SEC on Dec 1, 2025.
How long is this filing?
Ani Pharmaceuticals Inc's 8-K filing is 2 pages with approximately 606 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 606 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-12-01 06:58:48
Filing Documents
- ani-20251124.htm (8-K) — 28KB
- anip-20251124xexx991.htm (EX-99.1) — 14KB
- a1a.jpg (GRAPHIC) — 5KB
- 0001023024-25-000113.txt ( ) — 167KB
- ani-20251124.xsd (EX-101.SCH) — 2KB
- ani-20251124_lab.xml (EX-101.LAB) — 21KB
- ani-20251124_pre.xml (EX-101.PRE) — 12KB
- ani-20251124_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. The press release announcing the Board transitions described in Item 5.02 of this Current Report on Form 8-K is furnished as Exhibit 99.1 and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Exhibits
Item 9.01 Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated December 1, 2025 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 1, 2025 ANI PHARMACEUTICALS, INC. By: /s/ Stephen P. Carey Name: Stephen P. Carey Title: Senior Vice President Finance and Chief Financial Officer